Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Immunotherapy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Immunosuppressive Agents < Immunotherapy < Immunotherapy, Adoptive  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 57.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000194 (2020) Melissa Bersanelli [Italie]Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.
000411 (2019) Moshe C. Ornstein [États-Unis] ; Cassandra Calabrese [États-Unis] ; Laura S. Wood [États-Unis] ; Elizabeth Kirchner [États-Unis] ; Pamela Profusek [États-Unis] ; Kimberly D. Allman [États-Unis] ; Allison Martin [États-Unis] ; Apostolos Kontzias [États-Unis] ; Petros Grivas [États-Unis] ; Jorge A. Garcia [États-Unis] ; Leonard H. Calabrese [États-Unis] ; Brian I. Rini [États-Unis]Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors.
000520 (2019) Natalia Genere [États-Unis] ; Marius N. Stan [États-Unis]Current and Emerging Treatment Strategies for Graves' Orbitopathy.
000548 (2019) Damarcus E. Baymon [États-Unis] ; Edward W. BoyerChimeric antigen receptor T-cell toxicity.
000638 (2018) Nicolai Leuchten [Allemagne] ; Martin Aringer [Allemagne]Tocilizumab in the treatment of giant cell arteritis.
000639 (2018) Raimon Sanmartí [Espagne] ; Virginia Ruiz-Esquide [Espagne] ; Carla Bastida [Espagne] ; Dolor Soy [Espagne]Tocilizumab in the treatment of adult rheumatoid arthritis.
000649 (2018) Hilal Eser Ozturk [Turquie] ; Merih Oray [Turquie] ; Ilknur Tugal-Tutkun [Turquie]Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.
000693 (2018) Francesca Bartoli [Italie] ; Sangmee Bae [États-Unis] ; Laura Cometi [Italie] ; Marco Matucci Cerinic [Italie] ; Daniel E. Furst [États-Unis]Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018.
000755 (2018) Tania Jain ; Mark R. Litzow [États-Unis]No free rides: management of toxicities of novel immunotherapies in ALL, including financial.
000791 (2018) Abdul Rafeh Naqash [États-Unis] ; Li V. Yang [États-Unis] ; Edward J. Sanderlin [États-Unis] ; Druid C. Atwell [États-Unis] ; Paul R. Walker [États-Unis]Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report.
000792 (2018) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]Interleukin (IL-6) Immunotherapy.
000796 (2018) Margarida Figueiredo-Braga [Portugal] ; Caleb Cornaby [États-Unis] ; Alice Cortez [Portugal] ; Miguel Bernardes [Portugal] ; Georgina Terroso [Portugal] ; Marta Figueiredo [Portugal] ; Cristina Dos Santos Mesquita [Portugal] ; Lúcia Costa [Portugal] ; Brian D. Poole [États-Unis]Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis.
000808 (2018) Nirmala Chandralega Kampan [Australie] ; Sue D. Xiang [Australie] ; Orla M. Mcnally [Australie] ; Andrew N. Stephens [Australie] ; Michael A. Quinn [Australie] ; Magdalena Plebanski [Australie]Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities.
000810 (2018) Daniel J. Pallin [États-Unis] ; Christopher W. Baugh [États-Unis] ; Michael A. Postow [États-Unis] ; Jeffrey M. Caterino [États-Unis] ; Timothy B. Erickson [États-Unis] ; Gary H. Lyman [États-Unis]Immune-related Adverse Events in Cancer Patients.
000872 (2018) Ciriana Orabona [Italie] ; Giada Mondanelli [Italie] ; Maria T. Pallotta [Italie] ; Agostinho Carvalho [Portugal] ; Elisa Albini [Italie] ; Francesca Fallarino [Italie] ; Carmine Vacca [Italie] ; Claudia Volpi [Italie] ; Maria L. Belladonna [Italie] ; Maria G. Berioli [Italie] ; Giulia Ceccarini [Italie] ; Susanna Mr Esposito [Italie] ; Raffaella Scattoni [Italie] ; Alberto Verrotti [Italie] ; Alessandra Ferretti [Italie] ; Giovanni De Giorgi [Italie] ; Sonia Toni [Italie] ; Marco Cappa [Italie] ; Maria C. Matteoli [Italie] ; Roberta Bianchi [Italie] ; Davide Matino [Italie] ; Alberta Iacono [Italie] ; Matteo Puccetti [Italie] ; Cristina Cunha [Portugal] ; Silvio Bicciato [Italie] ; Cinzia Antognelli [Italie] ; Vincenzo N. Talesa [Italie] ; Lucienne Chatenoud [France] ; Dietmar Fuchs [Autriche] ; Luc Pilotte ; Benoît Van Den Eynde ; Manuel C. Lemos [Portugal] ; Luigina Romani [Italie] ; Paolo Puccetti [Italie] ; Ursula Grohmann [Italie]Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
000948 (2017) Melinda Zsuzsanna Szab ; Emese Kiss[Recent advances in the treatment of large vessel vasculitides].
000969 (2017) Aly M. Aly [Égypte] ; Daniel E. Furst [États-Unis]Update of sarilumb to treat rheumatoid arthritis based on randomized clinical trials: a systematic review.
000982 (2017) Dae Hyun Yoo [Corée du Sud]Treatment of adult-onset still's disease: up to date.
000A21 (2017) Charles SchmidtThe struggle to do no harm in clinical trials.
000A24 (2017) Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] ; Tadamitsu Kishimoto [Japon]The role and therapeutic targeting of IL-6 in rheumatoid arthritis.
000A49 (2017) Sang Taek Kim [États-Unis] ; Jean Tayar [États-Unis] ; Van Anh Trinh [États-Unis] ; Maria Suarez-Almazor [États-Unis] ; Salvador Garcia [États-Unis] ; Patrick Hwu [États-Unis] ; Daniel Hartman Johnson [États-Unis] ; Marc Uemura [États-Unis] ; Adi Diab [États-Unis]Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Immunotherapy" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Immunotherapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Immunotherapy
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021